Status:
ACTIVE_NOT_RECRUITING
Visualization of Asymptomatic Atherosclerotic Disease for Optimum Cardiovascular Prevention
Lead Sponsor:
Umeå University
Collaborating Sponsors:
Västerbotten County Council, Sweden
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
40-60 years
Phase:
NA
Brief Summary
The purpose of VIPVIZA is to assess the impact of pictorial information about asymptomatic atherosclerotic disease to both physician and patient, for improving physicians' adherence to prevention guid...
Detailed Description
Project description The main objective of this project is to contribute to improved primary prevention of cardiovascular disease through the provision of a visual image and pictorial report of athero...
Eligibility Criteria
Inclusion
- \- Participant in the Västerbotten Intervention Programme
- and
- 40 years old and a history of CVD at age \< 60 years among first-degree relative
- or
- 50 years old and at least one of the following six criteria:
- a history of CVD at age \< 60 years among first-degree relative,
- smoking,
- diabetes,
- hypertension,
- S-LDL-cholesterol ≥4.5 mmol/L,
- abdominal obesity
- or
- 60 years old
Exclusion
- Stenosis ≥50% of the carotid lumen
Key Trial Info
Start Date :
April 7 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2027
Estimated Enrollment :
3532 Patients enrolled
Trial Details
Trial ID
NCT01849575
Start Date
April 7 2013
End Date
December 31 2027
Last Update
January 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Reseach Center Umeå University Hospital
Umeå, Sweden, Se-90185